Therapeutic Expertise

Radiopharmaceutical

Full Life-Cycle Support and Services for Radiopharmaceutical Development.

Radiopharmaceutical Clinical Development

With the development of precision medicine, the radiopharmaceuticals (nuclear medicine) sector is quietly heating up, especially under the guidance of clinical value. The research and development of radiopharmaceuticals is gradually moving from laboratories to clinical applications. Currently, the global market share of radiopharmaceuticals is less than 1%, but they have significant market potential. This has attracted the attention of multinational giants, Chinese pharmaceutical companies, and research institutions, who are actively investing in the development of various radioligand therapies.

Tigermed team is providing phase I-IV clinical solutions for radiation therapies and diagnosis including regulatory, clinical strategy, medical writing, medical monitoring, clinical operation, biometrics, pharmacovigilance, imaging analysis, import-export logistic, etc.

Therapeutic Expertise

Radioactive Isotopes within Our Services

Build a Full-Chain Innovation Ecosystem for Radiopharmaceuticals

Supply Chain

Provide import and export customs clearance and transportation services for radiopharmaceuticals, coordinate management of radioactive isotopes (e.g. Lu-177, Ga-68, Y-90, etc.)

Development of Diagnosis and Therapy

Supporting the integrated development strategy of Radionuclide drug conjugates (RDCs) with our in-house central laboratories and imaging analysis.

Multidisciplinary Collaboration

Extensive data and site resources across various disease areas, particularly in oncology, which enable comprehensive coverage of current and emerging indications for radiopharmaceutical development

Let's Connect for a Conversation